Skip to the page

Data / Form D filings / Mizar Therapeutics, Inc.

Mizar Therapeutics, Inc.: Form D filing

Mizar Therapeutics, Inc., a health care company in Woods Hole, MA, filed a Form D with the SEC in 2025. The latest, on June 9, 2025, reports $518,616 sold of a $718,613 offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
PO, BOX 73, Woods Hole, MA, 02543
Phone
(626) 379-6659
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2070986

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 9, 2025New notice$718,613$518,616$199,9976May 9, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Paul MaddoxExecutive Officer, Director
Joel SmithExecutive Officer, Director

Other health care companies in Massachusetts that filed recently

Every Form D from the week of Jun 9, 2025 · All recent filings in Massachusetts · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Mizar Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.